IP Library › Granted Patent US 11,802,296
Granted Patent B2
US 11,802,296 · App. 17/728,790 · Granted Oct 31, 2023

Methods and systems for guide RNA design and use

Inventors: Richard Stoner (San Jose, CA); Travis Maures (Pacifica, CA); David Conant (San Francisco, CA)
Assignee: Synthego Corporation
C12N15/902C12N9/22C12N15/102C12N15/11C12N15/113C12N2310/20C12N2310/315C12N2310/321C12N2800/80
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,802,296
App. No.
17/728,790
Granted
Oct 31, 2023
Kind
B2
Abstract

The present disclosure provides a method for designing a set of guide RNAs for hybridizing a genomic region of interest. The present disclosure further provides methods of editing at least one genomic region of interest with at least one set of guide RNAs.

Claims (24)

1. A method for editing a gene within a genomic region of interest, the method comprising:

(a) contacting a cell comprising the gene within genomic region of interest with: a set of guide RNAs (gRNAs) comprising

(i) a first gRNA configured to hybridize to a first site of the genomic region of interest and capable of interacting with a nuclease and generating a first double stranded break;

(ii) a second gRNA configured to hybridize to a second site of the genomic region of interest and capable of interacting with the nuclease and generating a second double stranded break, and

(iii) a third gRNA configured to hybridize to a third site of the genomic region of interest and capable of interacting with the nuclease and generating a third double stranded break, wherein the first gRNA, second gRNA, and third gRNA are different and each hybridize to a site that is at least 15 base pairs and at most 2000 base pairs apart from each other; and

(b) introducing the set of gRNA and the nuclease into the cell to generate an edit that modifies the gene; wherein an editing efficiency of the set of gRNA is higher than an individual editing efficiency of each of the gRNAs.

2. The method of claim 1 , wherein the first gRNA, the second gRNA, and the third gRNA are configured to hybridize to the gene.

3. The method of claim 2 , wherein the first gRNA, the second gRNA, and the third gRNA are configured to hybridize an exon of the gene, a regulatory element, a cis-regulatory element or a trans-regulatory element.

4. The method of claim 3 , wherein the regulatory element is a cis-regulatory element and selected from the group consisting of: a promoter, an enhancer, and a silencer.

5. The method of claim 1 , further comprising introducing into the cell a donor polynucleotide.

6. The method of claim 5 wherein the donor polynucleotide comprises a point mutation, allele, tag or exogenous exon relative to a wild-type genotype of the cell.

7. The method of claim 1 , wherein the edit is a knock-out of the gene, an insertion or a deletion relative to wild-type.

8. The method of claim 7 , wherein the edit is an insertion and improves a function of the gene.

9. The method of claim 1 , wherein each of the first, second and third gRNA is hybridizable to a target site that is at least 30 bases apart from the target site of the other gRNA from the set of gRNAs.

10. The method of claim 1 , further comprising introducing a plurality of sets of gRNA targeting a plurality of genomic regions of interest.

11. The method of claim 1 , further comprising screening the population of cells for a phenotype.

12. The method of claim 1 , wherein the on-target efficiency threshold value for each guide RNA of the initial set of gRNAs is an azimuth score greater than 0.4.

13. The method of claim 1 , wherein the contacting comprises transfecting the cell with the set of gRNAs as ribonucleoprotein complexes.

14. The method of claim 1 , wherein the introducing comprises transfecting the cell with the set of gRNAs as ribonucleoprotein complexes.

15. The method of claim 1 , wherein the nuclease is Cas9 nuclease, C2c1 nuclease, C2c3 nuclease, or Cpf1 nuclease.

16. The method of claim 1 , wherein the first gRNA, the second gRNA, and the third guide RNA comprise a 5′ end modification and a 3′ end modification.

17. The method of claim 16 , wherein the 5′ end modification comprises a phosphorothioate internucleotide linkage and a 2′-O-methyl sugar modification and the 3′ end modification comprises a phosphorothioate internucleotide linkage and a 2′-O-methyl sugar modification.

18. The method of claim 17 , wherein the first gRNA, the second gRNA, and the third gRNA are single guide RNAs (sgRNAs), wherein the first binding site and the second binding site are separated by 15-80 base pairs, wherein the second binding site and the third binding site are separated by 15-80 base pairs, wherein the first binding site, the second binding site, and the third binding site are in an exon of a gene, wherein the exon is in a first half of the gene.

19. The method of claim 18 , wherein the first gRNA is configured to hybridize to a binding-site that is 30-80 base pairs apart from a binding site hybridizable to the second gRNA and the second gRNA is configured to hybridize to a binding-site that is 30-80 base pairs apart from a binding site hybridizable to the third gRNA.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 26, 2022
From: STONER, RICHARD; MAURES, TRAVIS; CONANT, DAVID
To: SYNTHEGO CORPORATION
Reel/Frame 059728/0335 →
Continuity (4)
Continuation 16418893 · May 21, 2019
Continuation PCTUS2019032735 · May 16, 2019
Provisional Application 62672437 · May 16, 2018
Related Publication 20220325300A1 · Oct 13, 2022